Among the agents classed in Group2B, possibly carcinogenic, are coffee and DDT, both of which have been extensively studied and found not be linked to cancer.
Writing in the Lancet medical journal, researchers from The International Hepatitis Interventional Therapy Group report a new treatment for chronic HCV infection that uses a combination of interferon alpha-2b and a drug called ribavirin.